Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Role of Antibodies Against Glutamate Receptors and Double Stranded DNA in Epilepsy Patients

NCT00317668 is registered in ClinicalTrials.gov with Hadassah Medical Organization as lead sponsor.

NCT NCT00317668
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00317668 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Role of Antibodies Against Glutamate Receptors and Double Stranded DNA in Epilepsy Patients
Lead sponsor
Hadassah Medical Organization
Phase
Observational
Overall status
Unknown status
Start date
November 30, 2006
Completion date
Not reported
Enrollment
250 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

epilepsy